NO790765L - Fremgangsmaate til fremstilling av urinstoffer og amidoforbindelser - Google Patents

Fremgangsmaate til fremstilling av urinstoffer og amidoforbindelser

Info

Publication number
NO790765L
NO790765L NO790765A NO790765A NO790765L NO 790765 L NO790765 L NO 790765L NO 790765 A NO790765 A NO 790765A NO 790765 A NO790765 A NO 790765A NO 790765 L NO790765 L NO 790765L
Authority
NO
Norway
Prior art keywords
procedure
preparation
amido compounds
urine substances
urine
Prior art date
Application number
NO790765A
Other languages
English (en)
Other versions
NO152606B (no
NO152606C (no
Inventor
Adrian Marxer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO790765L publication Critical patent/NO790765L/no
Publication of NO152606B publication Critical patent/NO152606B/no
Publication of NO152606C publication Critical patent/NO152606C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO790765A 1978-03-08 1979-03-07 Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser NO152606C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08

Publications (3)

Publication Number Publication Date
NO790765L true NO790765L (no) 1979-09-11
NO152606B NO152606B (no) 1985-07-15
NO152606C NO152606C (no) 1985-10-23

Family

ID=4235609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790765A NO152606C (no) 1978-03-08 1979-03-07 Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser

Country Status (28)

Country Link
US (2) US4292429A (no)
EP (1) EP0004561B1 (no)
JP (1) JPS54125668A (no)
KR (2) KR820002098B1 (no)
AR (2) AR225010A1 (no)
AT (1) AT364375B (no)
AU (1) AU531006B2 (no)
CS (1) CS244656B2 (no)
CY (1) CY1304A (no)
DD (1) DD142336A5 (no)
DE (1) DE2961198D1 (no)
DK (1) DK95279A (no)
ES (1) ES478342A1 (no)
FI (1) FI70708C (no)
GB (1) GB2016011B (no)
GR (1) GR71998B (no)
HK (1) HK80185A (no)
HU (1) HU182940B (no)
IL (1) IL56797A (no)
MY (1) MY8700199A (no)
NO (1) NO152606C (no)
NZ (1) NZ189841A (no)
OA (1) OA06201A (no)
PH (1) PH16207A (no)
PL (2) PL123150B1 (no)
PT (1) PT69314A (no)
SU (2) SU845779A3 (no)
ZA (1) ZA791062B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
JPS62501922A (ja) * 1984-12-12 1987-07-30 エム・ティー・ディー　メディカル　テクノロジー　アンド　ディベロプメント　リミテッド 病室等の装備方法
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
MX2007013683A (es) * 2005-05-03 2007-12-03 Pharma Mar Sa Tetrahidropirimidinas antitumorales.
FR2901273B1 (fr) * 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
EP2337731B1 (en) 2008-09-17 2015-03-11 William Kingston Tideway anchor system
HUE041362T2 (no) 2010-03-04 2019-05-28 Ea Pharma Co Ltd
EP2543660A4 (en) 2010-03-04 2014-04-30 Ajinomoto Kk PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST DIABETES OR ADIPOSITAS
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
EP0004561B1 (de) 1981-11-04
PH16207A (en) 1983-08-05
GB2016011B (en) 1982-08-25
PT69314A (de) 1979-04-01
DK95279A (da) 1979-09-09
NO152606B (no) 1985-07-15
OA06201A (fr) 1981-06-30
GR71998B (no) 1983-08-26
PL116762B1 (en) 1981-06-30
AT364375B (de) 1981-10-12
KR820002098B1 (ko) 1982-11-05
JPS629109B2 (no) 1987-02-26
US4292429A (en) 1981-09-29
GB2016011A (en) 1979-09-19
SU923367A3 (ru) 1982-04-23
ATA171079A (de) 1981-03-15
AU4490079A (en) 1979-09-13
HU182940B (en) 1984-03-28
NO152606C (no) 1985-10-23
CY1304A (en) 1985-12-06
FI790740A (fi) 1979-09-09
CS244656B2 (en) 1986-08-14
AU531006B2 (en) 1983-08-04
IL56797A (en) 1982-09-30
EP0004561A2 (de) 1979-10-17
FI70708B (fi) 1986-06-26
NZ189841A (en) 1982-03-09
HK80185A (en) 1985-10-25
PL123150B1 (en) 1982-09-30
SU845779A3 (ru) 1981-07-07
EP0004561A3 (en) 1979-11-14
DD142336A5 (de) 1980-06-18
PL213924A1 (no) 1980-02-25
KR830000884B1 (ko) 1983-04-26
US4420619A (en) 1983-12-13
AR225010A1 (es) 1982-02-15
FI70708C (fi) 1986-10-06
DE2961198D1 (en) 1982-01-14
AR227286A1 (es) 1982-10-15
JPS54125668A (en) 1979-09-29
MY8700199A (en) 1987-12-31
ZA791062B (en) 1980-03-26
ES478342A1 (es) 1979-05-16

Similar Documents

Publication Publication Date Title
NO790563L (no) Filtermateriale, samt fremgangsmaate til fremstilling av og anvendelse av dette
NO801600L (no) Fremgangsmaate for fremstilling av et bindemiddel for betong og moertler.
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO793836L (no) Fremgangsmaate og innretning for boeyning av glassplater
NO150879C (no) Fremgangsmaate for fremstilling av d-camforat av l-carnitinamid og d-camforat av d-carnitinamid
DK430079A (da) Katalysatorsammensaetning og fremgangsmaade til fremstilling af stive polyrethanskumstoffer
DK77580A (da) Fremgangsmaade til fremstilling af beta-lactamholdige forbindelser isaer penemcarboxylsyrer
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
NO791081L (no) Cementkomposisjoner og fremgangsmaate for fremstilling av disse
NO790765L (no) Fremgangsmaate til fremstilling av urinstoffer og amidoforbindelser
DK431879A (da) Fremgangsmaade til fremstilling af praeparater og konbinationer indeholdende adenosinderivater
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
NO834461L (no) Fremgangsmaate ved fremstilling av l-carnitin og utgangsmaterialer anvendt ved fremgangsmaaten
DK163379A (da) Fremgangsmaade til fremstilling af substituerede 1,3-diaryl-2-imino-imidazolidiner og 2-imino-hexahydro-pyrimidiner
NO783487L (no) Bindemiddel og fremgangsmaate til fremstilling av samme
DK267078A (da) Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf
NO790047L (no) Kompoundmaterialer og fremgangsmaate til deres fremstilling
DK209879A (da) Fremgangsmaade til fremstilling af aryleddikesyrederivater nellemprodukter hertil og disses fremstilling
DK224279A (da) Polyjodbenzenderivater og fremgangsmaade til fremstilling deraf
NO791349L (no) Fenoksyalkyl-trialkoksysilaner og fremgangsmaate til fremstilling av disse
DK431479A (da) Fremgagnsmaade til fremstilling af 3-exomethylencepham-sulfoxider
DK151570C (da) Afsvovlningsmiddel og fremgangsmaade til fremstilling deraf
NO794090L (no) Fremgangsmaate for fremstilling av klordioksyd